The microbiota‐derived metabolite phenylacetylglutamine (PAGln) is elevated in type 2 diabetes and tightly associated with poor healing in both diabetic and non‐diabetic human patients. PAGln promotes mouse inflammation and impairs healing through a transmissible β2‐adrenergic receptor–mediated trained‐immunity loop.
Lu Huang +12 more
wiley +1 more source
Modifying Our Environment to Improve Outcomes in Inflammatory Bowel Diseases? [PDF]
Fumery M, Richard N.
europepmc +1 more source
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study. [PDF]
Tsai SY +3 more
europepmc +1 more source
Histologic and Endoscopic Findings Are Highly Correlated in a Prospective Cohort of Patients With Inflammatory Bowel Diseases. [PDF]
Di Vincenzo F +10 more
europepmc +1 more source
Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance? [PDF]
Craveiro MMS +3 more
europepmc +1 more source
"Inside the Gut-Brain Axis": Psychological Profiles of Adolescents with Inflammatory Bowel Diseases and with Restrictive Eating Disorders. [PDF]
Riva A +6 more
europepmc +1 more source
Oxidative Stress, Gut Bacteria, and Microalgae: A Holistic Approach to Manage Inflammatory Bowel Diseases. [PDF]
Shoham S, Pintel N, Avni D.
europepmc +1 more source

